Effects of basic fibroblast growth factor on ischemic gut and liver injuries

Table 1 Changes in alanine transaminase in the three study groups

Group	ALT (nmol/L)
	0 h	6 h	24 h	48 h
1	792.7 ± 97.0	850.2 ± 498.1b	786.3 ± 308.6a	622.3 ± 134.9
2	925.2 ± 68.8	4777.6 ± 710.6	2771.2 ± 646.6	969.0 ± 105.7
3	1100.2 ± 148.5	858.5 ± 257.4	919.4 ± 170.0	923.5 ± 116.0

Data are expressed as (x^-± s).

^aP < 0.05;

^bP < 0.01 vs Group 2

Table 2 Changes of aspartate transaminase in the three study groups

Group	ALT (nmol/L)
	0 h	6 h	24 h	48 h
1	2130.9 ± 217.9	3453.5 ± 1532.1b	2155.9 ± 946.0a	2125.4 ± 437.6
2	2352.6 ± 281.2	7988.3 ± 1087.6	5845.7 ± 1274.8	3627.4 ± 695.3
3	3386.3 ± 587.5	3717.4 ± 1147.9	6079.0 ± 1464.0	2353.8 ± 242.9

Data are expressed as (x^-± s).

^aP < 0.05,

^bP < 0.01 , vs Group 2.

Table 3 Positive bacterial cultures from organs in the three study groups

Group	Positive bacterial cultures (%)
	Liver	Spleen	MLN
1	12.5a (1/8)	12.5a (1/8)	75.0 (6/8)
2	62.5 (5/8)	v57.1 (4/7)	62.5 (5/8)
3	0.0 (0/8)	0.0 (0/8)	50.0 (4/8)

^aP < 0.05 vs Group 2.

Table 4 Bacteria cultured from organ samples

Group	Organs sampled (n)	Positive (n)	Bacteria1 (log CFU/g tissue)
1	33	30	3.70 ± 0.91
2	9	8	4.06 ± 1.19
3	18	7	3.42 ± 0.50

¹Data expressed as x^-± s. CFU, colony forming unit